1-800-567-8911 or
604-682-5050
(Telephone interpreting in over 150 languages available)
Generic Name | Common Trade Name(s) | Classification | Date Marketed in Canada (yyyy/mm/dd) |
---|---|---|---|
Linezolid | Zyvoxam oral suspension | Antibacterial agent | 2010/08/04 |
Tramadol | Zytram XL | Opioid analgesic | 2011/03/01 |
Abiraterone | Zytiga | Androgen biosynthesis inhibitor | 2011/08/08 |
Zucapsaicin | Zuacta | Topical agent for joint and muscular pain | 2011/08/24 |
Zoster vaccine | Zostavax | Vaccine | 2009/08/11 |
Vorinostat | Zolinza | Histone deacetylase inhibitor, anti-neoplastic agent | 2009/06/17 |
Onasemnogene | Zolgensma | Cellular and gene therapy | 2021/02/04 |
Azithromycin dihydrate | Zmax SR | Antibiotic | 2010/10/29 |
Ceftobiprole | Zevtera | Cephalosporin antibiotic | 2018/03/20 |
Elbasvir + grazoprevir | Zepatier | Antiviral agent | 2016/02/02 |
Mometasone + formoterol | Zenhale | Corticosteroid + long-acting beta2- agonist | 2011/02/01 |
Vemurafenib | Zelboraf | Protein kinase inhibitor | 2012/03/06 |
Vemurafenib | Zelboraf | Antineoplastic agent | 2012/02 |
Niraparib | Zejula | Antineoplastic agent | 2020/01/09 |
Ceftobiprole medocaril | Zeftera | Cephalosporin antibiotic | 2010/04/16 |
Trabectedin | Yondelis | Antineoplastic agent | 2010/08/04 |
Axicabtagene ciloleucel | Yescarta | Antineoplastic agent | 2019/11/27 |
Ipilimumab | Yervoy | Antineoplastic agent | 2012/03 |
Moroctocog alfa | Xyntha | Hemostatic agent | 2009/01/23 |
Liraglutide + Insulin Degludec | Xultophy | Incretin mimetic + insulin | 2018/06/06 |
Enzalutamide | Xtandi | Antineoplastic agent | 2013/06/07 |
Gilteritinib | Xospata | Antineoplastic agent | 2020/02/03 |
Baloxavir marboxil | Xofluza | Antiviral agent | 2020/02/19 |
Lifitegrast | Xiidra | Lymphocyte function associated antigen-1 (LFA-1) antagonist | 2017/12/22 |
Drotrecogin alfa | Xigris | Antithrombotic profibrinolytic anti-inflammatory enzyme | 2011/10/25 |
Dapgliflozin + metformin | Xigduo | Sodium-glucose contransporter 2 (SGLT2) inhibitor plus metformin | 2016/02/08 |
Denosumab | Xgeva | Bone resorption inhibitor | 2011/10/05 |
Telotristat ethyl | Xermelo | Tryptophan hydroxylase inhibitor | 2018/10/12 |
Crizotinib | Xalkori | ALK Tyrosine Kinase Inhibitor | |
Lisdexamfetamine | Vyvanse | CNS stimulant | 2010/04/20 |
Tafamidis | Vyndaqel | Selective stabilizer of transthyretin - cardiac drug | 2020/04/07 |
Imiquimod | Vyloma | Immune response modifier | 2011/05/04 |
Eptinezumab | Vyepti | Prevention of migraine; calcitonin gene-related peptide binding antibody | 2021/01/11 |
Velaglucerase alfa | Vpriv | Enzyme replacement for treatment of Gaucher disease | 2010/11/22 |
Pazopanib | Votrient | Antineoplastic agent | 2011/08/25 |
Sofosbuvir + velpatasvir + voxilaprevir | Vosevi | Antiviral agent for treatment of chronic hepatitis C infection | 2017/09/18 |